Nuclear Medicine Program progress report for quarter ending March 31, 1990
The evaluation of the effects of albumin and albumin plus sodium palmitate in the phosphate buffer perfusate on the relative incorporation of 15-(p-(I-125)iodophenyl)-3-(R,S)-methylpentadecanoic acid (BMIPP) into endogenous lipids of isolated rat hearts has been studied. The effects of eluant salt character and concentration on the elution of (Re-188)perrhenate from the alumina-based tungsten-188/rhenium-188 generator system have also been investigated. During this period several agents were supplied to Medical Cooperative investigators, including (I-123)-labeled and (I-131)-labeled fatty acid analogues for studies at the Brookhaven National Laboratory and the Cardiology Department at the Free University of Amsterdam. Tungsten-188/rhenium-188 generators were supplied to the University of Massachusetts and the Center for Molecular Medicine and Immunology, in Newark, New Jersey. Osmium-191 was supplied for fabrication of generators for patient studies in Finland. 1 ref., 2 figs., 2 tabs.
- Research Organization:
- Oak Ridge National Lab., TN (USA)
- Sponsoring Organization:
- DOE/ER
- DOE Contract Number:
- AC05-84OR21400
- OSTI ID:
- 7015943
- Report Number(s):
- ORNL/TM-11550; ON: DE90013608
- Country of Publication:
- United States
- Language:
- English
Similar Records
Nuclear Medicine Program progress report for quarter ending June 30, 1990
Nuclear Medicine Program progress report for quarter ending September 30, 1989
Nuclear Medicine Program progress report for quarter ending September 30, 1990
Technical Report
·
Wed Aug 01 00:00:00 EDT 1990
·
OSTI ID:6939010
Nuclear Medicine Program progress report for quarter ending September 30, 1989
Technical Report
·
Thu Nov 30 23:00:00 EST 1989
·
OSTI ID:5358657
Nuclear Medicine Program progress report for quarter ending September 30, 1990
Technical Report
·
Thu Jan 31 23:00:00 EST 1991
·
OSTI ID:6228890
Related Subjects
550500 -- Metabolism
550600* -- Medicine
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
ABSORPTIVITY
ALBUMINS
ANIMALS
ANTIBODIES
AQUEOUS SOLUTIONS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BODY
CARBOXYLIC ACIDS
CARDIOVASCULAR SYSTEM
CHELATING AGENTS
CHEMICAL REACTIONS
CHEMISTRY
DAYS LIVING RADIOISOTOPES
DISPERSIONS
DOCUMENT TYPES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EVEN-EVEN NUCLEI
HALOGENATION
HEART
HEAVY NUCLEI
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINATION
IODINE 123
IODINE 131
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MAMMALS
MEDICINE
MINUTES LIVING RADIOISOTOPES
MIXTURES
MONOCARBOXYLIC ACIDS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
OPTICAL PROPERTIES
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PHYSICAL PROPERTIES
PROGRESS REPORT
PROTEINS
RADIOCHEMISTRY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RATS
RHENIUM 188
RHENIUM ISOTOPES
RODENTS
SOLUTIONS
SYNTHESIS
TUNGSTEN 188
TUNGSTEN ISOTOPES
VERTEBRATES
550600* -- Medicine
59 BASIC BIOLOGICAL SCIENCES
62 RADIOLOGY AND NUCLEAR MEDICINE
ABSORPTIVITY
ALBUMINS
ANIMALS
ANTIBODIES
AQUEOUS SOLUTIONS
BETA DECAY RADIOISOTOPES
BETA-MINUS DECAY RADIOISOTOPES
BIOLOGICAL EFFECTS
BODY
CARBOXYLIC ACIDS
CARDIOVASCULAR SYSTEM
CHELATING AGENTS
CHEMICAL REACTIONS
CHEMISTRY
DAYS LIVING RADIOISOTOPES
DISPERSIONS
DOCUMENT TYPES
DRUGS
ELECTRON CAPTURE RADIOISOTOPES
EVEN-EVEN NUCLEI
HALOGENATION
HEART
HEAVY NUCLEI
HOURS LIVING RADIOISOTOPES
INTERMEDIATE MASS NUCLEI
INTERNAL CONVERSION RADIOISOTOPES
IODINATION
IODINE 123
IODINE 131
IODINE ISOTOPES
ISOMERIC TRANSITION ISOTOPES
ISOTOPES
LABELLED COMPOUNDS
MAMMALS
MEDICINE
MINUTES LIVING RADIOISOTOPES
MIXTURES
MONOCARBOXYLIC ACIDS
NUCLEAR MEDICINE
NUCLEI
ODD-EVEN NUCLEI
ODD-ODD NUCLEI
OPTICAL PROPERTIES
ORGANIC ACIDS
ORGANIC COMPOUNDS
ORGANS
PHYSICAL PROPERTIES
PROGRESS REPORT
PROTEINS
RADIOCHEMISTRY
RADIOISOTOPES
RADIOPHARMACEUTICALS
RATS
RHENIUM 188
RHENIUM ISOTOPES
RODENTS
SOLUTIONS
SYNTHESIS
TUNGSTEN 188
TUNGSTEN ISOTOPES
VERTEBRATES